Its Receptor in Ovarian Cancer Expression of Insulin-like Growth Factor I , Its Binding Proteins

Insulin-like growth factor (IGF) I is a polypeptide hormone important in normal growth and development. Although IGF-I is a mitogen for many cancer cell lines, previous work has suggested that autocrine production of IGF-I is uncommon in cancers of epithelial origin. In this study, expression of IGF-I, its binding proteins, and its receptor were examined in ovarian cancer cell lines and tissues. Of 10 ovarian cancer cell lines, 3 (OVCAR-3, OVCAR-7, and PEO4) expressed IGF-I mRNA. RNase protection assays using probes derived from IGF-IA, IGF-IB, and alternate exon 1 IGF-I complementary DNAs demonstrated that these cells contained a predominant IGF-I transcript with an alternate first exon. RNA extracted from primary and metastatic ovarian cancer tissues also expressed IGF-I mRNAs (7 of 7) with the alternate first exon. IGFI protein was detected in OVCAR-3-conditioned media; this activity was secreted in conjunction with several IGF-binding proteins (IGFBPs). IGFBP-2, IGFBP-3, an M, 24,000 species, and an M, 30,000 species could also be demonstrated in OVCAR-3. Type I IGF receptor mRNA was found in all 10 of the ovarian cancer cell lines and all 7 of the primary or metastatic ovarian cancer tissues. IGF-I was a mitogen for OVCAR3, demonstrating the presence of a functional type I IGF receptor. These data show that all the necessary components for an IGF-I-mediated autocrine loop are expressed by ovarian cancer cells.

[1]  Shan-Chun Chen,et al.  Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. , 1991, Cancer research.

[2]  I. Scott,et al.  A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours. , 1991, British Journal of Cancer.

[3]  D. Yee,et al.  Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. , 1990, The Journal of clinical investigation.

[4]  D. Yee,et al.  A novel human insulin-like growth factor I messenger RNA is expressed in normal and tumor cells. , 1990, Molecular endocrinology.

[5]  S. Mohan,et al.  Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. , 1990, Molecular endocrinology.

[6]  C. Osborne,et al.  Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. , 1990, Endocrinology.

[7]  T. Bauknecht,et al.  In situ distribution of transforming growth factor α in normal human tissues and in malignant tumours of the ovary , 1990, The Journal of pathology.

[8]  L. A. Scott,et al.  Insulin and insulin-like growth factor I in early development: peptides, receptors and biological events. , 1990, Endocrine reviews.

[9]  D. Clemmons,et al.  A factor contained in plasma is required for IGF binding protein‐1 to potentiate the effect of IGF‐I on smooth muscle cell DNA synthesis , 1990, Journal of cellular physiology.

[10]  F. Rojas,et al.  Insulin-like growth factors and thecal-granulosa-cell function. , 1990, Human reproduction.

[11]  N. Ling,et al.  Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. , 1990, Molecular endocrinology.

[12]  G. Mills,et al.  Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. , 1990, The Journal of clinical investigation.

[13]  D. Yee,et al.  Identification of an alternate type I insulin-like growth factor receptor beta subunit mRNA transcript. , 1989, The Journal of biological chemistry.

[14]  G. Jaques,et al.  Production of insulin-like growth factor binding proteins by small-cell lung cancer cell lines. , 1989, Experimental cell research.

[15]  Christopher C. Binkert,et al.  Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2). , 1989, The EMBO journal.

[16]  M. Israel,et al.  Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. , 1989, The Journal of clinical investigation.

[17]  D. Yee,et al.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. , 1989, Molecular endocrinology.

[18]  R. Bast,et al.  Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. , 1989, The Journal of clinical investigation.

[19]  P. Rotwein,et al.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. , 1989, Endocrine reviews.

[20]  E. Adashi,et al.  Potential Relevance of Insulin-Like Growth Factor I to Ovarian Physiology: From Basic Science to Clinical Application , 1989 .

[21]  D. Yee,et al.  Insulin-like growth factor II mRNA expression in human breast cancer. , 1988, Cancer research.

[22]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[23]  W. Rutter,et al.  Expression and characterization of a functional human insulin-like growth factor I receptor. , 1988, The Journal of biological chemistry.

[24]  G. Mills,et al.  A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. , 1988, Cancer research.

[25]  C. Wolf,et al.  Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient , 1987, International journal of cancer.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  G. Bell,et al.  Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. , 1987, Endocrinology.

[28]  W. Daughaday,et al.  Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. , 1987, The Journal of laboratory and clinical medicine.

[29]  R. Baxter,et al.  Insulin-like growth factor-binding protein from human plasma. Purification and characterization. , 1986, The Journal of biological chemistry.

[30]  G. Bauer,et al.  Characterization of growth factors in human ovarian carcinomas. , 1986, Cancer research.

[31]  D. K. Didier,et al.  Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. , 1986, The Journal of biological chemistry.

[32]  M. Binoux,et al.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.

[33]  W. Sly,et al.  Insulin-like growth factor receptor expression and function in human breast cancer. , 1990, Cancer research.

[34]  A. Nienhuis,et al.  Private and public autocrine loops in neoplastic cells. , 1989, Cancer cells.

[35]  R. Baxter,et al.  Binding proteins for the insulin-like growth factors: structure, regulation and function. , 1989, Progress in growth factor research.

[36]  E. Froesch,et al.  Insulin and Insulin-Like Growth Factor I , 1987 .